Green Thumb Industries GTBIF
OTC GTBIF
$7.62 +0.37 (+5.10%)
At close: Aug 19, 2026 · 3:59 PM UTC

Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Amortization of Deferred Charges came in at $13.4 million in Q1 2026, up 5.33% YoY from $12.8 million in Q1 2025, and up 8305.0% on a QoQ basis from $160000.0 in Q4 2025.

Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Amortization of Deferred Charges data on file, last reported at $13.4 million in Q1 2026.

  • Quarterly Amortization of Deferred Charges rose 5.33% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 90.4% YoY) and the FY2025 annual result came in at $639000.0, down 79.21% from the prior year.
  • Amortization of Deferred Charges advanced to $13.4 million in Q1 2026, from $160000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $31.2 million in Q3 2023 to a low of -$25.1 million in Q3 2025.
  • A 5-year average of $4.4 million and a median of $2.4 million in 2023 frame the typical range for Amortization of Deferred Charges.
  • The widest YoY moves for Amortization of Deferred Charges: up 1148.72% in 2022, down 177.93% in 2022.
  • Tracing GTBIF's Amortization of Deferred Charges over 5 years: stood at -$22.7 million in 2022, then soared by 153.82% to $12.2 million in 2023, then slumped by 98.69% to $160000.0 in 2024, then changed by 0.0% to $160000.0 in 2025, then jumped by 8305.0% to $13.4 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $13.4 million (Q1 2026), $160000.0 (Q4 2025), and -$25.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Green Thumb Industries 1.65 Bn 1.37 Bn 137.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 13.71 Mn
Jun 30, 2026 13.71 Mn
Mar 31, 2026 13.45 Mn
Mar 31, 2026 13.45 Mn
Dec 31, 2025 160,000.00
Dec 31, 2025 160,000.00
Sep 30, 2025 -25.09 Mn
Sep 30, 2025 -25.09 Mn
Jun 30, 2025 12.80 Mn
Jun 30, 2025 12.80 Mn
Mar 31, 2025 12.77 Mn
Mar 31, 2025 12.77 Mn
Dec 31, 2024 160,000.00
Dec 31, 2024 160,000.00
Sep 30, 2024 -21.76 Mn
Sep 30, 2024 -21.76 Mn
Jun 30, 2024 22.58 Mn
Jun 30, 2024 22.58 Mn
Mar 31, 2024 2.10 Mn
Mar 31, 2024 2.10 Mn